|
the contents of MDA and LPO in cell membrane of group II,III were lower than that of the control group,the differences were significant(P<0.05).
|
|
|
②Fenton体系作用后,受试Ⅰ、Ⅱ两组细胞膜中MDA和LPO较对照组降低均有显著性差异(P<0.05)。 |
|
the differential expression of 8 apoptosis-associated genes were found with gene array. The expression of Fas-L and Bag-1 detected by RT-PCR were consistent with those detected by gene array.
|
|
|
通过基因芯片检测发现,60μmol/L DADS作用4h后有8个凋亡相关基因表达差异显著,选择其中Fas-L和Bag-1两个基因运用RT-PCR技术进行验证,其结果与基因芯片结果一致。 |
|
the expression of NF-_κB correlated with tumor differentiation and AFP level of hepatocelluar carcinoma(P＜0.05),while no correlated was found with sex,age,HbsAg. hepatocirrhosis,Child degree, and tumor diameter(P＞0.05).
|
|
|
NF—κB表达与性别、年龄、HBsAg、Child分级、肝硬化背景、肿块大小无相关(P＞0．05),与HCC分化程度、AFP水平相关(P＜0．05)。 |
|
there was cooperative action in combination of TTD with MDR-1 antonym RNA, CDA-II and hyperthermia.
|
|
|
TTD与MDR-1反义核酸、CDA-II、加温有协同逆转作用； CDA-II与加温有协同逆转作用； |
|
there were correlations between P-AKT expression and lymph node metastasis,between the TNM stage and differentiation of NSCLC(P<0.05) and between VEGF expression and lymph node metastasis and the TNM stage of NSCLC(P<0.05).
|
|
|
P-AKT的表达与肺癌的分化程度、分期、淋巴结转移密切相关(P<0.05)。 VEGF的表达与肺癌的分期、淋巴结转移密切相关(P<0.05)。 |
|
there were correlations between the MVD and lymph node metastasis and between the TNM stage and differentiation of NSCLC(P<0.05).
|
|
|
MVD值的高低与肺癌的分期、转移、分化程度密切相关(P<0.05)。 |
|
two groups all cut down immunoglobulin,treatment group was superior to that in the control group(P<0.05).
|
|
|
2组均能降低免疫球蛋白,组间比较治疗组优于对照组(P<0.05); |
|
uPA receptor on cell surface has localized activation on uPA.
|
|
|
细胞膜上受体uPA—R对uPA活性具有定位活化作用。 |
|
when the differentiation degree was different,the difference of FHIT expression in the lung carcinoma was very significant(P<0.01), and FHIT expression was positive correlation with differentiation degree(r=0.608, P<0.01);
|
|
|
分化程度不同肺癌组织,FHIT表达差异有极显著性(P<0.01),且FHIT基因表达与肺癌组织分化程度正相关(P<0.01); |
|
~(18)O Labeling and Its Application in Quantitative Proteomics
|
|
|
~(18)O标记法在定量蛋白质组学中的应用 |
|
~(31)P MR Spectroscopy Imaging of Liver : Initial Clinical Study
|
|
|
~(31)P MR波谱成像在肝脏的初步临床应用研究 |
